For Durect Investors, Cash and Revenues Limit Downside

Published March 5, 2013

For Durect Investors, Cash And Revenues Limit Downside

Filed under: drug abuse treatment association inc

Relday. In July 2011, Durect and Zogenix, Inc. (ZGNX) entered into a license agreement to develop and commercialize a proprietary, long-acting injectable formulation of risperidone using Durect's SABER controlled release formulation technology in …
Read more on Seeking Alpha

Don't Miss the Sentinel's Feature on Drug Addiction

Filed under: drug abuse treatment association inc

… treatment such as a drug court. On a national level, about 80 percent of criminal behavior is related to drugs and alcohol and 75 percent of those incarcerated are there because of a drug- or alcohol-related crime, according to the National …
Read more on Free Keene